Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Quadrise Raises GBP1.1 Mln via Share Placing to Progress Operations, Projects -- Update

Por: MarketWatch Business July 07, 2023

thumbnail

The company has now issued 88 million new ordinary shares under the placing at 1.25 pence each. The issue price is a 34% discount to Thursday's closing price of 1.90 pence. Shares at 0945 GMT were down 0.65 pence, or 34%, at 1.25 pence. The money will be used to progress operations and projects through to at least February 2024, Quadrise said. The company is also offering shareholders the chance to buy the discounted shares via an open... + full article



Similar News

Kingfisher FY 2023 Profit Fell, Sees Further Drop in Year Ahead -- 2nd Update

MarketWatch USA Business March 21, 2023

thumbnailThe home-improvement retailer posted a pretax profit for the year ended Jan. 31 of 611 million pounds ($750.1 million) compared with GBP1.01 billion a year earlier. Analysts expected GBP740.8 million in profit, according to forecasts taken from FactSet and based on eight... + más

Kingfisher Profits Slump 39% As Retailer Suffers Following Covid Reopening | Forbes

Kingfisher FY 2023 Profit Fell, Sees Further Drop in Year Ahead -- 2nd Update | MarketWatch


GSK 4Q Sales and Earnings Rose, Driven by Specialty Medicines, Vaccines -- Update

MarketWatch USA Business February 01, 2023

thumbnailOperating profit increased to GBP1.87 billion from GBP492 million in the fourth quarter of 2021, reflecting fair-value gains on investments, milestone income from disposals and lower remeasurement charges for contingent consideration liabilities, GSK said. After-tax profit also... + más

GSK vaccine for older adults granted FDA priority review | Fox Business

GSK 4Q Sales and Earnings Rose, Driven by Specialty Medicines, Vaccines -- Update | MarketWatch


GSK 4Q Sales and Earnings Rose, Driven by Specialty Medicines, Vaccines -- Update

MarketWatch USA Business February 01, 2023

thumbnailOperating profit increased to GBP1.87 billion from GBP492 million in the fourth quarter of 2021, reflecting fair-value gains on investments, milestone income from disposals and lower remeasurement charges for contingent consideration liabilities, GSK said. After-tax profit also... + más

GSK vaccine for older adults granted FDA priority review | Fox Business

GSK 4Q Sales and Earnings Rose, Driven by Specialty Medicines, Vaccines -- Update | MarketWatch


Currys 1H Could Be Affected by Higher Costs, Lower Margins -- Earnings Preview

MarketWatch USA Business December 14, 2022

thumbnailPRETAX PROFIT FORECAST: Curry's pretax profit is expected to fall to GBP18.0 million from GBP48 million a year ago, according to one analyst estimation taken from FactSet. ADJUSTED PRETAX LOSS FORECAST: The company could report a swing to adjusted pretax loss--the... + más

Currys Bets On Tech Revolution As It Takes On Amazon For Black Friday | Forbes

Stephen, Ayesha Curry host a winter wonderland for 500 kids, families in need this holiday season | ABC News


GSK Raises 2022 Guidance as 3Q Sales Beat Expectations -- Update

MarketWatch USA Business November 02, 2022

thumbnailOperating profit was GBP1.19 billion, down slightly from GBP1.38 billion, due to the fair-value loss on the retained stake in consumer-healthcare business Haleon, which was spun off earlier in the year. Total earnings per share also fell to 18.8 pence from 21.9 pence for the... + más

GSK Raises 2022 Guidance as 3Q Sales Beat Expectations -- Update | MarketWatch

GSK 3Q Sales Expected Lower, But Possible Guidance Upgrade on the Horizon -- Earnings Preview | MarketWatch


GSK Raises 2022 Guidance as 3Q Sales Beat Expectations -- Update

MarketWatch USA Business November 02, 2022

thumbnailOperating profit was GBP1.19 billion, down slightly from GBP1.38 billion, due to the fair-value loss on the retained stake in consumer-healthcare business Haleon, which was spun off earlier in the year. Total earnings per share also fell to 18.8 pence from 21.9 pence for the... + más

GSK Raises 2022 Guidance as 3Q Sales Beat Expectations -- Update | MarketWatch

GSK 3Q Sales Expected Lower, But Possible Guidance Upgrade on the Horizon -- Earnings Preview | MarketWatch


GSK 3Q Sales Expected Lower, But Possible Guidance Upgrade on the Horizon -- Earnings Preview

MarketWatch USA Business October 31, 2022

thumbnailNET INCOME: Net income at the British pharma major is expected to increase only slightly to GBP1.62 billion from GBP1.17 billion the year prior, according to a company-provided consensus. EPS: Earnings per share are expected at 40.1 pence, from 23.1 pence the previous year. WHAT... + más

Horizon Worlds metaverse app so bad that Meta has to force employees to use it | 9to5Mac

Meta’s VR social network Horizon is too buggy and employees are barely using it | The Verge



About iurex | Privacy Policy | Disclaimer |